JFGIW
HBIO icon

Johnson Financial Group Inc (Wisconsin)’s Harvard Bioscience HBIO Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$1.13K – 794
2025
Q1 		$1.13K Buy
+200
New +$2.56K ﹤0.01% 833

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s HBIO Position: Q2 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 200 shares — an estimated $1.13K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in HBIO in Q1 2025 and held it in 1 quarter. The position peaked at $1.13K in Q1 2025. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 200 Harvard Bioscience shares in Q2 2025, an estimated $1.13K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Harvard Bioscience in Q1 2025 and held it in 1 quarter.
  • Johnson Financial Group Inc (Wisconsin)'s Harvard Bioscience position peaked at $1.13K in Q1 2025.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2025, filed 13 Aug 2025.